The online version of this article (doi:10.1186/s12877-017-0690-2) contains supplementary material, which is available to authorized users.
To examine factors predicting type of bladder antimuscarinics (BAM) initiated in nursing home (NH) residents.
Incident BAM initiators following NH admission were identified by constructing a retrospective cohort from Medicare files and Minimum Data Set (MDS). Participants included all residents 65 years and older admitted in Medicare-certified NH between January 1, 2007 and December 31, 2008 who were prescribed BAM and had continuous Medicare (Part A, B, and D) enrollment. Patient characteristics, medications, and comorbidities were derived from Medicare enrollment and claims. NH characteristics and health status were derived from MDS assessments. The outcome was defined as type of BAM initiated after admission (selective, non-selective extended release, non-selective immediate release). Multinomial logistic regression using generalized estimating equation methodology determined which factors predicted the type of BAM initiated.
Twelve thousand eight hundred ninety-nine NH residents initiating BAM therapy were identified; 13.38% of new users were prescribed selective BAM, 45.56% non-selective extended release, and 41.07% non-selective immediate release medications. In both sexes, significant predictors of BAM included region of nursing home, body mass index, cognitive performance score, frailty measures, activities of daily living, and measures of bladder continence. In women, history of fracture and fall-related injuries were significant predictors of type of BAM use, while race and indicators of balance were significant predictors of type of BAM use in men. Non-pharmacological continence management strategies were not predictive of type of BAM initiation.
Several factors are important in predicting type of BAM initiation in both women and men, but other factors are sex-specific. Some observed factors predicting the type of BAM initiated, such as other medications use, body mass index, or provider-related factors are potentially modifiable and could be used in targeted interventions to help optimize BAM use in this population.
Additional file 1: Table S1. Bladder Antimuscarinics- Important Drug Characteristics and Relevant Clinical Information. This supplementary table contains a summary of the important strengths and weaknesses of each bladder antimuscarinic medication included within this study, as well as a description of each medications’ M1-M5 receptor affinity. (DOCX 24 kb)
Abrams P, et al. The standardization of terminology of lower urinary function: report from the standardization sub-committee of the international continence society. Neurol Urodyn. 2002;21:167–78. CrossRef
Coyne KS, et al. Economic burden of urgency urinary incontinence in the United States: a systematic review. J Manag Care Pharm. 2014;20(2):130–40. PubMed
Charalambous S, Trantafylidis A. Impact of urinary incontinence on quality of life. Pelviperineology. 2009;28:51–5.
Wilson L, et al. Annual direct cost of urinary incontinence. Obstet Gynecol. 2001;98(3):398–406. PubMed
Moga DC, et al. Bladder antimuscarinics and cognitive decline in elderly patients. Alzheimers Dement (N Y). 2017;3(1):139–48.
Ikeda K, et al. M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland. Naunyn Schmiedeberg’s Arch Pharmacol. 2002;366(2):97–103. CrossRef
Napier C, Gupta P. Darifenacin is selective for the human recombinant M3 receptor subtype [abstract]. Neurourol Urodyn. 2002;21:A445.
Hartmaier S, et al. The MDS cognition scale: a valid instrument fo identifying and staging nursing home residents with dementia using the minimum data set. J Am Geriatr Soc. 1994;1994(42):1173–9. CrossRef
Mahoney F, Barthel D. Functional evaluation: the Barthel index. MD State Med J. 1965;14:61–5. PubMed
SAS Institute Inc., SAS 9.4 Help and Documentation, Cary, NC: SAS Institute Inc.; 2013.
Smith DB, Feng Z, Fennell ML, Zinn JS, Mor V. Separate and unequal: racial segregation and disparities in quality across US nursing homes. Health Aff. 2007;26(5):1448–58. CrossRef
- An investigation of factors predicting the type of bladder antimuscarinics initiated in Medicare nursing homes residents
Daniela C. Moga
Amie J. Goodin
- BioMed Central
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II